在住院的COVID-19患者中,埃索诺菲尔和慢性阻塞性肺病 (COPD)
Mitra Samareh Fekri1, Zohreh Najminejad2, Fatemeh Karami Robati2
1Cardiovascular Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran. mitra.samareh.fekri@gmail.com.
BMC infectious diseases
|June 3, 2024
概括
患有COVID-19的慢性阻塞性肺病 (COPD) 患者的低乙氨基酸细胞数量表明疾病更严重,结果更差. 这一发现有助于识别有针对性的管理策略的高风险个体.
科学领域:
- 肺部医学 肺部医学
- 传染性疾病 传染性疾病
- 血液学 血液学 血液学
背景情况:
- COVID-19 流行病带来了重大风险,特别是在慢性阻塞性肺病 (COPD) 患者身上.
- 了解COPD患者的疾病进展对于有效管理至关重要.
- 作为COPD中COVID-19严重程度的潜在生物标志物,埃索诺菲尔水平需要进行调查.
研究的目的:
- 在COPD患者中调查eosinophilia和COVID-19严重程度之间的关系.
- 为了确定外围血液中乙氨基酸的百分比是否可以预测这种患者群体的不良结果.
主要方法:
- 一项涉及73名COVID-19感染COPD患者的横截面研究.
- 通过使用Giemsa染色来评估外周血液中乙酸氨基基基因百分比,乙酸氨基基基因被定义为≥2%.
- 通过胸部CT严重性得分 (CT-SS) 和氧和水平来评估COVID-19的严重程度.
主要成果:
- 非乙醇性COPD患者 (乙醇<2%) 呈现出更严重的COVID-19.
- 在非eosinophilic患者中观察到较低的氧和度 (P=0.001) 和较高的CT-SS (P<0.001).
- 虽然非乙酸性患者的死亡率较高,但这种差异在统计学上并不显著 (P=0.16).
结论:
- 患有COVID-19的COPD患者的外周血液中乙氨基酸水平降低与不良结果相关.
- 这种关联可以帮助识别高风险的COPD患者,需要更密切的监测和及时干预.
- 了解乙酸蛋白的作用可能会导致改善COPD中COVID-19的预后评估和管理策略.
更多相关视频
相关概念视频
01:22Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
01:26COPD: Management Using Bronchodilators and Corticosteroids
195
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
195
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
01:20COPD: Pathogenesis and Clinical Features
259
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
259
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K